Experiments by Pitha‐Rowe and colleagues identified that UBE1L, the E1‐activating enzyme of ISGylation, is induced by ATRA treatment in ATRA‐sensitive but not ATRA‐resistant APL cells (Kitareewan et al., 2002). Here, UBA7 is linked to acute promyelocytic leukemia.